Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
UFI | US
0.08
2.06%
Consumer Cyclical
Textile Manufacturing
30/06/2024
06/03/2026
3.97
3.80
3.99
3.80
Unifi Inc. together with its subsidiaries manufactures and sells recycled and synthetic products in the United States China Brazil and internationally. Its polyester products include partially oriented yarn textured solution and package dyed twisted beamed and draw wound yarns in virgin or recycled varieties; and nylon products comprise virgin or recycled textured solution dyed and spandex covered yarns. The company also provides recycled solutions made from pre-consumer and post-consumer waste such as plastic bottle flake made from polyester and polymer beads and staple fiber made from polyester or nylon. It offers recycled and synthetic products primarily to yarn manufacturers knitters and weavers that produce fabric for the apparel hosiery home furnishings automotive industrial and other end-use markets. The company sells its products through sales force and independent sales agents under the REPREVE brand. Unifi Inc. was incorporated in 1969 and is headquartered in Greensboro North Carolina.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
32.2%1 month
37.7%3 months
55.6%6 months
50.6%-
227.27
0.48
0.53
0.30
-13.74
0.41
12.72
-4.21M
72.47M
72.47M
-
-0.33
-74.60
4.20
-16.15
4.47
1.60
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.50
Range1M
0.91
Range3M
1.56
Rel. volume
0.40
Price X volume
81.65K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 0.9708 | 77.29M | -2.92% | n/a | 1.07% |
| Cannex Capital Holdings Inc | ARRXF | Drug Manufacturers-Specialty & Generic | 0.2542 | 64.78M | 5.92% | n/a | 0.50% |
| Universe Pharmaceuticals INC | UPC | Drug Manufacturers-Specialty & Generic | 2.72 | 64.32M | 0.74% | n/a | 24.34% |
| Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 3.5 | 49.33M | -0.57% | n/a | 81.86% |
| Lipocine Inc | LPCN | Drug Manufacturers-Specialty & Generic | 8.13 | 43.48M | -0.73% | n/a | 0.00% |
| INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 0.8202 | 37.54M | -3.55% | n/a | 28.90% |
| SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 0.8 | 30.29M | 0.95% | n/a | 25.73% |
| Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.0523 | 21.96M | 0.00% | n/a | 0.00% |
| India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.2859 | 21.62M | -1.41% | n/a | 4.33% |
| China SXT Pharmaceuticals Inc | SXTC | Drug Manufacturers-Specialty & Generic | 2.04 | 7.09M | 0.00% | n/a | 19.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -13.74 | - | - |
| Ent. to Revenue | 0.41 | - | - |
| PE Ratio | - | - | - |
| Price to Book | 0.48 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 55.63 | - | - |
| Debt to Equity | 0.53 | - | - |
| Debt to Assets | 0.30 | - | - |
| Market Cap | 72.47M | - | - |